Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy

In this study, we aimed to evaluate the efficacy and safety of tacrolimus-based treatment for immunoglobulin A nephropathy (IgAN). We retrospectively reviewed 127 adult patients with primary IgAN with 24 h urine total protein quantity (24 h UTP) ≥ 1 g and serum creatinine ≤3 mg/dL. All patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lijuan, Yang, Yanyan, Xu, Hao, Leng, Wei, Xu, Guoshuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232819/
https://www.ncbi.nlm.nih.gov/pubmed/37274107
http://dx.doi.org/10.3389/fphar.2023.1189608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232819/
https://www.ncbi.nlm.nih.gov/pubmed/37274107
http://dx.doi.org/10.3389/fphar.2023.1189608

Ejemplares similares